CoreCap Advisors »

Biomarin Pharmaceutical shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.7k 6.0k 0.95

More positions owned by CoreCap Advisors

State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard S&p 500 Etf Etf (VOO)
State Street Technology Select Sector Spdr Etf Etf (XLK)
Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Schwab U.s. Small-cap Etf Etf (SCHA)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Ishares Core S&p 500 Etf Etf (IVV)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Growth Etf Etf (VUG)

View all positions for CoreCap Advisors

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Jpmorgan Chase & Co

View all funds holding Biomarin Pharmaceutical